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Background: Liver cirrhosis is a pathological condition that describes the end stage 
of hepatic fibrotic which progressively ongoing that signed by distortion from hepar 
architecture and the formation of the regenerative modulus. Liver cirrhosis causes 
impairment in most of the liver function including the hormonal balance and 
metabolism of steroids. In the male patients, liver cirrhosis causes hypogonadism and 
feminization. Sexual dysfunction in cirrhotic patients is still underestimated and 
underdiagnosed. The most common sexual dysfunction in male cirrhotic patients is 
impotence or erectile dysfunction. Erectile dysfunction (ED) is define as a 
persistence inability to reach and/ or maintain enough erection to satisfy the sexual 
activity. International Index of Erectile Function 5/IIEF-5 could mark erectile 
dysfunction. Despite the prevalence of erectile dysfunction is high in patients with 
liver cirrhosis, only a few studies revealing the relationship between severity of liver 
cirrhosis and severity of erectile dysfunction. 
The purpose of this study is to determine the correlation between MELD 
score and severity of erectile dysfunction (IIEF-5 score) in cirrhosis patients. 
This study is observational with a cross-sectional method. Subjects were 
patients with liver cirrhosis, male, age 18 to 65 years old, married, have a partner, and 
agreed participated to this study. We used Pearson the correlation to assess 
correlation between severity of liver cirrhosis (Child Pugh score) and severity of 
erectile dysfunction (IIEF-5 score) if the data were distributed normally and Spearman 
correlation if the distribution is abnormal. 
 




Latar belakang: Sirosis hati adalah kondisi patologis yang menggambarkan tahap akhir fibrotik 
hepatik yang semakin berlanjut yang ditandai dengan distorsi dari arsitektur hepar dan 
pembentukan modulus regeneratif. Sirosis hati menyebabkan kerusakan pada sebagian besar 
fungsi hati termasuk keseimbangan hormonal dan metabolisme steroid. Pada pria, sirosis hati 
menyebabkan hipogonadisme dan feminisasi. Disfungsi seksual pada pasien sirosis masih 
diremehkan dan kurang terdiagnosis. Disfungsi seksual yang paling umum pada pasien pria 




dengan sirosis adalah impotensi atau disfungsi ereksi. Disfungsi ereksi (DE) didefinisikan sebagai 
ketidakmampuan untuk mencapai dan / atau mempertahankan ereksi yang cukup untuk 
memuaskan aktivitas seksual. Indeks Internasional Fungsi Ereksi 5 / IIEF-5 dapat menandai 
disfungsi ereksi. Meskipun prevalensi disfungsi ereksi tinggi pada pasien dengan sirosis hati, hanya 
sedikit penelitian yang mengungkapkan hubungan antara tingkat keparahan sirosis hati dan 
tingkat keparahan disfungsi ereksi. 
Tujuan: Tujuan dari penelitian ini adalah untuk mengetahui korelasi antara skor MELD dan 
tingkat keparahan disfungsi ereksi (skor IIEF-5) pada pasien sirosis. 
Penelitian ini bersifat observasional dengan metode cross-sectional.  
Metode: Subjek penelitian adalah pasien sirosis hati, pria, usia 18 sampai 65 tahun, menikah, 
memiliki pasangan, dan setuju berpartisipasi dalam studi ini. Kami menggunakan korelasi 
Pearson untuk menilai korelasi antara tingkat keparahan sirosis hati (skor Child Pugh) dan 
tingkat keparahan disfungsi ereksi (skor IIEF-5) jika data didistribusikan secara normal dan 
korelasi Spearman jika distribusinya abnormal. 
 
Kata kunci: sirosis hati, skor MELD, disfungsi ereksi, IIEF-5, korelasi 
 
INTRODUCTION 
Cirrhosis of the liver is a 
pathological condition that describes 
the final stage of hepatic fibrosis, 
which lasts progressively characterized 
by distortion of the liver architecture 
and nodule formation regenerative1. 
Clinically, cirrhosis described as a 
compensation or decompensation. 
Decompensation means cirrhosis with 
one or more complications of the 
following symptoms: jaundice, ascites, 
hepatic encephalopathy or variceal 
bleeding. Ascites is usually the first 
marker. Ascites was produced from 
sinusoidal hypertension and sodium 
retention. Hepatorenal syndrome, 
hyponatremia and spontaneous 
bacterial peritonitis (SBP) can also 
describe the decompensation, but in 
this patient, the first time is always the 
case ascites. Compensated cirrhosis 
patients do not obtain these 
symptoms. 
Classification of Child-
Turcotte-Pugh (CTP) has become the 
reference for more than 30 years to 
assess the prognosis of liver cirrhosis. 
Scores CTP has limitations because it 
comes from some of the experienced 
variables that affect the prognosis 
empirically. Among several new 
prognostic scores of liver cirrhosis 
reported in the literature, the score 
Model of End-Stage Liver Disease 
(MELD) is the best alternative to CTP 
score. MELD scores are prepared to 
overcome the limitations and replace 
CTP score. This score is composed 
based on a group of variables that are 
meaningful and independent of output 
through multivariate analysis 4. MELD 
scores are very useful in patients with 
cirrhosis of the liver with a wide 
variety of disease severity and etiology 
of cirrhosis even in patients who have 
unexplained causes 5. 
Cirrhosis of the liver causes 
disturbances in the majority of liver 
function, including hormonal balance 
and metabolism of steroid 6. In men, 
liver cirrhosis causes occur 
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hypogonadism and feminization 6.7. 
Sexual dysfunction in patients with 
liver cirrhosis is still underdiagnosed 
and underestimates 8. Erectile 
dysfunction (ED) is defined by 
persistent inability to attain and/or 
maintain an erection sufficient for 
satisfactory sexual activity 9. Erectile 
dysfunction can be assessed by the 
International Index of Erectile 
Function 5 / IIEF-5 10. The 
assessment is validated by the 
Indonesian Medical Association in 
1999. Most of the research in 
Indonesia also uses these instruments 
for the diagnosis of erectile 
dysfunction. The prevalence of ED in 
patients with cirrhosis are by 93% (age 
30-79 years) largely ED weight (43%) 
11. 
 ED high prevalence in patients 
with liver cirrhosis, but the data is still 
limited research, few studies revealing 
the relationship between the degrees 
of severity of cirrhosis of the liver 
with the degree of erectile 
dysfunction. 
The aim of research is to 
determine the relationship between 
MELD score with the severity of 
erectile dysfunction (IIEF-5 scores), in 
patients with liver cirrhosis. 
 
MATERIAL  AND METHODS 
 The study design was cross-
sectional. Subjects were patients with 
liver cirrhosis treated at the clinic of 
Internal Medicine at the Hospital Dr. 
Sardjito, in January 2014 to December 
2014. Inclusion criteria male, age 18 to 
65 years old, married, has a life 
partner, willing to follow the research, 
Diagnosis of liver cirrhosis was 
established by ultrasound checkup, 
supported by clinical and laboratory 
data from medical records. 
Exclusion criteria were 
patients with (1) cognitive disorders / 
communication, (2) diabetes mellitus, 
(3) Congestive heart failure, (4) a 
history of stroke, (5) Chronic kidney 
disease, (6) malignancy, (7) a history of 
prostate surgery, (8) a history of spinal 
trauma, (9) peripheral arterial disease, 
(10) the symptoms of major 
depression (BDI score> 31), (11) 
symptoms of severe anxiety. 
 
Liver cirrhosis patients who 
met the inclusion and exclusion 
criteria were included in the study. All 
study subjects given an explanation 
and signed a letter of approval of 
participation in the study. 
Demographic data, clinical and 
laboratory parameters were collected 
from all study subjects. The 
chronology of the study were shown 
in Figure 1. 
  





Figure 1. Flow Research 
MELD scores assessed by a 
research assistant, using laboratory 
data (levels of bilirubin, albumin, INR 
(international normalized ratio), serum 
creatinine. Values obtained expressed 
as a MELD score. The degree of 
erectile dysfunction determined was 
by the International Index of Erectile 
Function 5 / IIEF-5). Patients fill the 
IIEF-5 is guided by a research 
assistant. Having obtained the IIEF-5 
score and MELD score then 
performed statistical analysis. 
Univariable analysis is 
conducted with descriptive analysis to 
look at the characteristics of the 
subject. Categorical data will be seen 
on the frequency distribution with the 
percentage proportion, while the 
numeric data will be the mean and 
standard deviation. 
For bivariable analysis with 
independent variable / independent 
and dependent variable/ depending 
on the form of scale, the numerical 
data analysis using Pearson correlation 
test for numerical distribution data but 
if the data is not normally distributed 
using Spearman correlation test 12. 
The correlation is very strong giving 
values (r = 0.80 -1.00); strong (r = 
0.60 to 0.79); moderate (r = 0.40 to 
0.59); low (r = .20-.39); very low (r = 
0.00 to 0.19) 13. 
 
RESULT AND DISCUSSION 
The research of correlation 
between the severity of liver cirrhosis 
(MELD score) with the degree of 
erectile dysfunction (IIEF-5 score) in 
the patient with liver cirrhosis is a 
cross sectional research. Subject of the 
research is the patient with liver 
cirrhosis conducting outpatient 
treatment in the polyclinic og Gastro-
Entero-Hepatologi in the section of 
Internal Medicine in Dr. Sardjito 
Hospital Yogyakarta since November 
2014 to November 2015. 
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There are 40 patients 
appropriate with the inclusion criteria 
and research exclusion. All of male 
patiens with the mean age of 
48.93+10.30 years. Most of the cause 
of liver cirrhosis is hepatitis B amount 
25 patients (62.5%). The distribution 
of patients is based on the duration of 
suffering hepatitic cirrhosis with the 
median 1 (1-27 years). Median score 
MELD  is 13.5 (4-37) and the median 
score of  IIEF-5 is 14 (5-25).   
To understand the correlation 
between MELD score with the IIEF-5 
score was conducted a correlation 
pearson test if the data distribution is 
normal and spearman test if the 
distribution is abnormal. In this 
research obtained the existence of 
correlation between the MELD score 
and IIEF-5 score with the p-value 
0,001 and r score is -0.748 and the 
determination coefficient is r2 55.95%. 
It could be concluded that if the 
upgrading of MELD score so will be 
found reduction in IIEF-5 score with 
the moderate correlation with the 
correlation strength 55.95%. 
 
Table 1 Basic Characteristics of the Subject of Research on Patient with Liver Cirrhosis, n= 40 




Completer Elementary School 13 (32.5) 
Completer Junior High School 8 (20) 
Completer Senior High School 15 (37.5) 
Completer D3/S1 4 (10) 
Clinically  
History of Smoking  
No 23 (57.5) 
Yes 1 (2.5) 
        History 16 (40) 
Alcohol Consumption  
No 36 (90) 
History 4 (10) 
Cause of Cirrhosis  
Hepatitis B 25 (62.5) 
Hepatitis C 7 (17.5) 
NAFLD 1 (2.5) 
Other 7 (17.5) 
The duration of suffering cirrhosis (year) 1 (1-27) 
MELD Score 13.5 (4-37) 
IIEF-5 Score 14 (5-25) 
The circle of upper arm 10.8+4.74 
BDI score 10.8+4.74 
HAM-A score 6 (1-20) 
Laboratory  




Haemoglobin (mg/dl) 10.66+1.96 
GDS (mg/dl) 99.5 (72-172) 
Creatinin (mg/dl) 0.98 (0.54-2.86) 
Total Bilirubin (mg/dl) 2.15 (0.3-41.40 
INR 1.46 (1-3.62) 
Pharmacological  
Spironolactone dosage  (mg) 50 (0-200) 
Notes : ES : Elementary School, JHS: Junior 
High School, SHS : Senior High School, D3/S1 
:Diploma 3/ Scholar,  NAFLD: Non Alcoholic 
Fatty Liver Disease,  MELD: Model of End Stage 
Liver Disease, IIEF-5: International Index of Erectile 
Function 5, BDI: Beck Depression Inventory, HAM-A: 
Hamilton Anxiety Scale, GDS: Blood sugar at one 
time, INR: International Normalized Ratio. 
 
The result of this research is 
similar with the research conducted by 
Toda et al (2005), the increase of severity 
degree in Erectile Dysfunction has 
positive correlation with the increase of 
child pugh class (P <0.05). Muhammad 
et al (2012), cirrhosis patient with ED 
incline to the high severity group (child 
C) (p <0.000). 
 
Table 3. Correlation of various variable potential to be confusing factor of erectile dysfunction 
Variable IIEF-5 Score 
 Correlation Coefficient (r) p value 
Age -0.193 0.232 
Education NA 0.619 
Occupation NA 0.351 
Smoking History NA 0.357 
Alcohol Consumption History NA 0.08 
Upper Arm Circle 0.287 0.73 
BDI Score -0.136 0.401 
HAM_A Score -0.23 0.154 
Hemoglobin -0.23 0.44 
Sspironolactone Dosage -0.356 0.024* 
Information *) p score< 0.05, BDI: Beck Depression Inventory, HAM-A: Hamilton Anxiety Scale  
P-value 0,001 
r score  -0,748 




Spironolactone was used on the 
patient with asites. Side effect of 
spironolactone as the consequence of 
direct effect anti androgen. That side 
effect related with the dosage and the 




From this research can be 
concluded that there is negative 
correlation with the moderate strength 
degree between MELD score (the 
degreee of severity in liver cirrhosis) with 
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